Clinical Pediatric Emergency Medicine
Volume 9, Issue 4 , Pages 250-257 , December 2008

Fever After International Travel

References 

  1. United States Department of Transportation, Research and Innovative Technology Administration Bureau of Transportation Statistics . U.S. International Travel and Transportation Trends: 2006 Update. Washington, DC: Bureau of Transportation Statistics; 2006;Available at: http://tinet.ita.doc.gov/view/f-2003-07-001/Accessed 10/4/08
  2. United States Department of Commerce, International Trade Administration, Office of Travel and Tourism . In-flight survey. Washington, DC: Office of Travel and Tourism Industries; 2003;Available at: http://www.bts.gov/publications/us_international_travel_and_transportation_trends/2006/index.htmlAccessed 10/4/08
  3. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis. 1987;156:84–91
  4. Hill DR. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med. 2000;7:259–266
  5. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel surveillance network. Clin Infect Dis. 2007;44:1560–1568
  6. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119–130
  7. Centers for Disease Control and Prevention . Treatment of malaria (guidelines for clinicians). Available at http://www.cdc.gov/malaria/diagnosis_treatment/tx_clinicians.htmAccessed 5-1-2008
  8. Centers for Disease Control and Prevention . Travelers' Health. Available at: http://wwwn.cdc.gov/travel/default.aspxAccessed 4-26-2008
  9. Sethuraman U, Kamat D. Management of child with fever after international travel. Clin Pediatr. 2007;46:222–227
  10. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med. 2002;347:505–516
  11. American Academy of Pediatrics . Red Book: 2006 report of the Committee on Infectious Diseases. Elk Grove Village (Ill): American Academy of Pediatrics; 2006;
  12. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States. JAMA. 2007;297:2264–2277
  13. Thwing J, Skarbinski J, Newman RD, et al. Malaria surveillance—United States, 2005. MMWR Surveill Summ. 2007;56:24–40
  14. O'Brien D, Tobin S, Brown G, et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis. 2001;33:603–609
  15. Dorsey G, Gandhi M, Ouygi JH, et al. Difficulties in the prevention, diagnosis and treatment of imported malaria. Arch Intern Med. 2000;160:2505–2510
  16. Singh K, Wester WC, Trenholme GN. Problems in the therapy for imported malaria in the United States. Arch Intern Med. 2003;163:2027–2030
  17. Krause PJ. Malaria (Plasmodium). In:  Behrman RE,  Kliegman RM,  Jenson HB editor. Nelson's textbook of pediatrics. 17th ed.. Philadelphia (Pa): W.B. Saunders; 2004;p. 1139–1143
  18. Leggat PA. Assessment of febrile illness in the returned traveler. Aus Fam Phys. 2007;36:328–333
  19. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Micribiol Rev. 1998;11:480–496
  20. Rush B. An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. In:  Rush B editors. Medical inquiries and observations. Philadelphia (Pa): Prichard and Hall; 1789;p. 104–117
  21. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563–1566
  22. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100–103
  23. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med. 2005;353:924–932
  24. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330–342
  25. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42
  26. Gubler DJ. Epidemic dengue and dengue hemorrhagic fever: a global public health problem in the 21st century. In:  Scheld WM,  Armstrong D,  Hughes JM editor. Emerging infections. Vol. 1:Washington, DC: ASM Press; 1998;p. 1–14
  27. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322–330
  28. Cobra C, Rigau-Perez JG, Kuno G, et al. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am J Epidemiol. 1995;142:1204–1211
  29. Deen JL, Harris E, Willis B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet. 2006;368:170–173
  30. World Health Organization . Dengue haemorrhagic fever: treatment. Available at: http://www.who.int/csr/resources/publications/dengue/024-33.pdfAccessed 5-12-2008
  31. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Org. 2004;82:346–353
  32. Aekers ML, Puhr ND, Tauxe RV, et al. Laboratory based surveillance of Salmonella serotype Typhi infections in the United States. JAMA. 2000;283:2668–2673
  33. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med. 2002;347:1770–1782
  34. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child. 1996;75:214–217
  35. van Basten JP, Stockenbrugger R. Typhoid perforation: a review of the literature since 1960. Trop Geograph Med. 1994;46:336–339
  36. Stephens I, Levine MM. Management of typhoid fever in children. Pediatr Infect Dis. 2002;21:157–159
  37. Wain J, Diep TS, Ho VA, et al. Quantitation of bacteremia in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol. 1998;36:1683–1687
  38. Wain J, Bay VB, Ha V, et al. Quantitation of bacteremia in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol. 2001;39:1571–1576
  39. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ. 2006;333:78–82
  40. World Health Organization . Background document: the diagnosis, treatment and prevention of typhoid fever. Available at: http://www.who.int/vaccine_research/documents/en/typhoid_diagnosis.pdfAccessed: 8-10-2008
  41. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a practical guide or physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55:1–27
  42. Centers for Disease Control and Prevention . Traveler's health: yellow book, rickettsial infections. Available at: http://wwwn.cdc.gov/travel/yellowBookCh4-Rickettsial.aspxAccessed: 5-21-2008
  43. Rolain JM, Jensenius M, Raoult D. Rickettsial infections—a threat to travellers?. Curr Opin Infect Dis. 2004;17:433–437
  44. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757–771
  45. McBride AJA, Athanazio DA, Reis MG, et al. Leptospirosis. Curr Opin Infect Dis. 2005;18:376–386
  46. Griffith ME, Hospenthal DR, Murray CK. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis. 2006;19:533–537
  47. Bovet P, Yersin C, Merein F, et al. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles. Int J Epidemiol. 1999;28:583–590
  48. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326
  49. Vinetz JM, Glass GE, Flexner CE, et al. Sporadic urban leptospirosis. Ann Intern Med. 1996;125:794–798
  50. Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis. 2005;40:343–351
  51. Watt G, Padre L, Tuazon M, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet. 1988;1:433–435
  52. World Health Organization . Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: World Health Organization; 2003;
  53. Panaphut T, Domrongkitchaipom S, Vibhagool A, et al. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003;36:1507–1513
  54. Vinetz J. A mountain out of a molehill: do we treat acute leptospirosis, and if so, with what?. Clin Infect Dis. 2003;36:1514–1515

PII: S1522-8401(08)00066-9

doi: 10.1016/j.cpem.2008.09.002

Clinical Pediatric Emergency Medicine
Volume 9, Issue 4 , Pages 250-257 , December 2008

Article Tools